Shulun Nie

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Tumour morphology as a visible readout of cancer biology: Towards artificial intelligence-enabled multimodal risk stratification in anal squamous cell carcinoma.

Tumour morphology as a visible readout of cancer biology: Towards artificial intelligence-enabled multimodal risk stratification in anal squamous cell carcinoma.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: July 10, 2026

First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II Trial.

First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 26, 2026

Leveraging Minimal Variables for Maximal Screening Yield: A Global Equity Perspective on Colorectal Cancer Risk Stratification.

Leveraging Minimal Variables for Maximal Screening Yield: A Global Equity Perspective on Colorectal Cancer Risk Stratification.

Journal: International journal of cancer

Published: June 09, 2026

Predicting Intratumoral Heterogeneity and Stratifying Prognostic Risk in Gastric Cancer Using a Histology-Based Pathomics-Deep Learning Fusion Model.

Predicting Intratumoral Heterogeneity and Stratifying Prognostic Risk in Gastric Cancer Using a Histology-Based Pathomics-Deep Learning Fusion Model.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: January 28, 2026

Survival and multi-omics analysis of immunotherapy-based conversion treatment for initially unresectable gastric cancer.

Survival and multi-omics analysis of immunotherapy-based conversion treatment for initially unresectable gastric cancer.

Journal: Frontiers in immunology

Published: November 25, 2025

Development and validation of a machine learning model for predicting immune checkpoint inhibitor efficacy in advanced gastric cancer using dynamic changes in peripheral blood clinlabomics data: a retrospective multicenter cohort study.

Development and validation of a machine learning model for predicting immune checkpoint inhibitor efficacy in advanced gastric cancer using dynamic changes in peripheral blood clinlabomics data: a retrospective multicenter cohort study.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: April 23, 2025

Genomic landscape of paired primary and peritoneal metastatic lesions in gastric cancer highlights evolutionary dynamics and mutational drivers.

Genomic landscape of paired primary and peritoneal metastatic lesions in gastric cancer highlights evolutionary dynamics and mutational drivers.

Journal: Journal of advanced research

Published: February 26, 2025

Correction: Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study.

Correction: Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study.

Journal: BMC medicine

Published: February 12, 2025

N6-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis.

N6-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis.

Journal: Cancer communications (London, England)

Published: August 21, 2024

Timing and clinical significance of chemotherapy in patients with resected gastric adenocarcinoma: a population-based cohort study.

Timing and clinical significance of chemotherapy in patients with resected gastric adenocarcinoma: a population-based cohort study.

Journal: The oncologist

Published: August 07, 2024

Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study.

Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study.

Journal: BMC medicine

Published: May 09, 2024

Comparison of treatment regimens for unresectable stage III epidermal growth factor receptor ( EGFR ) mutant non-small cell lung cancer.

Comparison of treatment regimens for unresectable stage III epidermal growth factor receptor ( EGFR ) mutant non-small cell lung cancer.

Journal: Chinese medical journal

Published: December 04, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026